Oct 6, 2012 |
Correction: Immunovative, Inc. Announces Collaboration With The Robert H. Lurie Compehensive Cancer Center of Northwestern University |
Oct 4, 2012 |
Immunovative, Inc. Announces Collaboration With the Robert H. Lurie Comprehensive Cancer Center at the Northwestern University Feinberg School of Medicine |
Sept 28, 2012 |
Immunovative, Inc. Moves Corporate Headquarters to Danbury, Connecticut Effective October 01, 2012 |
Sept 21, 2012 |
Immunovative, Inc. Announces the Appointment of Mr. Bruce Harmon as Chief Financial Officer, Effective Immediately |
Sept 4, 2012 |
Immunovative, Inc. Announces the Appointment of Members to the Scientific Advisory Board |
Aug 22, 2012 |
Immunovative, Inc. Announces the Appointment of Mr. Seth M. Shaw as Chief Executive Officer and Chairman of the Board of Directors |
Aug 15, 2012 |
Immunovative, Inc. Announces the Appointment of Dr. Laurence Terrisse-Rulleau to Business Advisory Board |
Aug 13, 2012 |
Immunovative, Inc. Provides Update on Enhanced Intellectual Property Portfolio Focused on Immunotherapy Drugs That Incorporate Living Immune Cells |
Aug 8, 2012 |
Immunovative, Inc. Announces Oversubscription of Its $5,000,000 Private Placement |
Aug 6, 2012 |
Immunovative, Inc. Completes $5,000,000 Private Placement With Institutional and Accredited Individual Investors |